Suspension of trading
Centessa Pharmaceuticals plc Share Price
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.5B 5.12B 4.71B 8.83B 599B 8.98B 60.76B 23.78B 297B 23.53B 23.02B 1,026B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.34B 4.98B 4.58B 8.58B 582B 8.73B 59.05B 23.11B 289B 22.86B 22.37B 997B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +2.64% | ||
| 6 months | +60.46% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 28/02/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 31/03/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 23/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 23/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Issuer sale | Compliance Officer | -1,376,483 | 0.8896% | ||
| 24/06/26 | Issuer sale | Director | -711,155 | 0.4596% | ||
| 24/06/26 | Issuer sale | Director | -392,474 | 0.2537% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +166.45% | +408.16% | 6.27B | |
| +0.14% | -0.67% | -0.88% | +11.02% | 47.74B | |
| -2.24% | +0.31% | +393.45% | +615.13% | 39.98B | |
| +1.40% | +3.69% | +12.21% | +46.79% | 36.23B | |
| +13.94% | +20.49% | +22.85% | +7.42% | 35.59B | |
| -0.73% | +3.38% | +4.94% | +41.45% | 27.91B | |
| +0.40% | -0.30% | - | - | 16.71B | |
| -3.12% | +7.39% | +26.03% | +124.08% | 16.45B | |
| +2.39% | -1.64% | +4.74% | +9.95% | 13.21B | |
| +6.79% | +8.17% | -4.97% | -28.52% | 12.93B | |
| Average | +1.98% | +2.86% | +69.42% | +137.28% | 25.3B | |
| Weighted average by Cap. | +2.07% | +2.52% | +78.51% | +137.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 13.16 12.26 11.27 21.14 1.43K 21.5 145.43 56.92 710.7 56.31 55.1 2.46K |
| Net income | -236M -207M -193M -177M -332M -22.52B -338M -2.29B -895M -11.17B -885M -866M -38.59B | -198M -173M -161M -148M -278M -18.87B -283M -1.92B -750M -9.36B -742M -726M -32.34B |
| Net Debt | -364M -320M -298M -274M -513M -34.81B -522M -3.53B -1.38B -17.26B -1.37B -1.34B -59.64B | -176M -155M -144M -132M -248M -16.83B -253M -1.71B -669M -8.35B -661M -647M -28.84B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
